1. Main page
  2. Biotechnology
  3. Xencor

Xencor

10 Decision Makers Β· 11 Verified Contacts & Email Format

xencor.com
πŸ“ Monrovia, California, United StatesBiotechnologyπŸ—“ Est. 1997πŸ‘₯ 251–500 employees πŸ’° $50M–$100M

About Xencor

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Email Format

{first_name}.{last_name}@xencor.com β€” 100.0%

sarah.smith@xencor.com

Leadership & Decision Makers

Contact details of 10 Xencor decision makers

John Kuch

Senior Vice President & Chief Scientific Officer

  • Work email

    j*******h@xencor.com

Bassil Dahiyat

CEO

Dane Leone

SVP of Corporate Strategy

David Szymkowski

Vice President of Preclinical Operations

Nancy Valente

Executive Vice President & Chief Development Officer

Kenneth Hung

Senior Vice President, Clinical Development

Jennifer Sandoz

Senior Vice President Human Resources

Jeremy Grunstein

Senior Vice President of Business Development

Bart Cornelissen

Chief Financial Officer

Debra Jeske Zack,

Vice President

Team & Specialists

Contact details of 1 Xencor team members

John Desjarlais

Vice President, Research,Chief Scientific Officer

General Emails

General company emails, e.g. customer support lines

    info@xencor.com

    General Inquiries

    john.kuch@xencor.com

    Unclassified inbox

    ebaracchini@xencor.com

    Unclassified inbox

    nsoni@xencor.com

    Unclassified inbox

    sdanowski@xencor.com

    Unclassified inbox

    anisthal@xencor.com

    Unclassified inbox

Verify Xencor Emails

Similar Companies like Xencor

Kite Pharma

kitepharma.com
Biotechnology Β· Los Angeles, CA Β· Est. 2009 Β· 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology Β· Lebanon, New Hampshire, United States Β· Est. 2007 Β· 101–250 employees

HQ: Lebanon, New Hampshire, United States

Seagen

seagen.com
Biotechnology Β· Bothell, Washington, United States Β· Est. 1998 Β· 1001–5000 employees Β· $500M–$1B

HQ: Bothell, Washington, United States

Alexion Pharmaceuticals

alexion.com
Biotechnology Β· Cheshire, Connecticut, United States Β· Est. 1992 Β· 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology Β· Temple City, California, United States Β· Est. 2011 Β· 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

xencor.com

626-305-5900

Monrovia, California, United States

Specialization: Therapeutics,
Legal Name: Xencor, Inc.
Business Type: Public
Employees: 251-500
Annual Revenue: $50M–$100M
Rounds: Post-IPO Equity
Founded Date: 1997
Company Type: For Profit
Stock Symbol: NASDAQ:XNCR
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 626-305-5900
Last Investment Activity: Feb 28, 2024
Investments Activity: Feb 28, 2024 Feb 28, 2024 Feb 27, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.